Prehypertension Is Not Associated with All-Cause Mortality: A Systematic Review and Meta-Analysis of Prospective Studies

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Guo, Xiaofan ^a   Zhang, Xiaoyu ^b   Zheng, Liqiang ^a   Guo, Liang ^a   Li, Zhao ^a   Yu, Shasha ^a   Yang, Hongmei ^a   Zhou, Xinghu ^a   Zou, Lu ^a   Zhang, Xingang ^a   Sun, Zhaoqing ^a   Li, Jue ^c   Sun, Yingxian ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Fourth People's Hospital of Shenyang   (China)

^c TONGJI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALL CAUSE MORTALITY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CLINICAL EVALUATION; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREHYPERTENSION; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; META ANALYSIS; PROSPECTIVE STUDY;

HUMANS; PREHYPERTENSION; PROSPECTIVE STUDIES;

EID: 84876717016     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061796     Document Type: Article

References (45)

1. Ezzati M, Lopez AD, Rodgers A, Hoorn SV, Murray CJL, et al. (2002) Selected major risk factors and global and regional burden of disease. Lancet 360: 1347-1360.
2. Gaziano TA, Bitton A, Anand S, Weinstein MC, (2009) International Society of Hypertension (2009) The global cost of nonoptimal blood pressure. J Hypertens 27(7): 1472-1477.
3. Lawes CM, Vander Hoorn S, Rodgers A, (2008) International Society of Hypertension (2008) Global burden of blood-pressure-related disease, 2001. Lancet 371: 1513-1518.
4. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, et al. (2005) Global burden of hypertension: analysis of worldwide data. Lancet 365: 217-223.
5. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, et al. (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360: 1903-1913.
6. He FJ, MacGregor GA, (2003) Cost of poor blood pressure control in the UK: 62, 000 unnecessary deaths per year. J Hum Hypertens 17: 455-457.
7. He J, Gu D, Chen J, Wu X, Kelly TN, et al. (2009) Premature deaths attributable to blood pressure in China: a prospective cohort study. Lancet 374(9703): 1765-1772.
8. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, et al. (2003) Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42: 1206-1252.
9. Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, et al. (2001) Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 345(18): 1291-1297.
10. Asayama K, Ohkubo T, Kikuya M, Metoki H, Hoshi H, et al. (2004) Prediction of stroke by self-measurement of blood pressure at home versus casual screening blood pressure measurement in relation to the Joint National Committee 7 classification: the Ohasama study. Stroke 35(10): 2356-2361.
11. Kalaitzidis RG, Bakris GL, (2010) Prehypertension: is it relevant for nephrologists? Kidney Int 77(3): 194-200.
12. Pimenta E, Oparil S, (2010) Prehypertension: epidemiology, consequences and treatment. Nat Rev Nephrol 6(1): 21-30.
13. Carlsson AC, Theobald H, Hellénius ML, Wändell PE, (2009) Cardiovascular and total mortality in men and women with different blood pressure levels-A 26-year follow-up. Blood Press 18(3): 105-110.
14. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al. (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283: 2008-2012.
15. Moher D, Liberati A, Tetzlaff J, Altman DG, (2009) PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 21 6(7): e1000097.
16. Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, et al. (2001) Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med 20(3 Suppl): 21-35.
17. Smith GL, Lichtman JH, Bracken MB, Shlipak MG, Phillips CO, et al. (2006) Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol 47(10): 1987-1996.
18. Lee M, Saver JL, Chang KH, Liao HW, Chang SC, et al. (2010) Impact of microalbuminuria on incident stroke: a meta-analysis. Stroke 41(11): 2625-2631.
19. Higgins JPT, Green S (2008) Cochrane handbook for systematic reviews of interventions. Cochrane Collaboration.
20. Mainous AG 3rd, Everett CJ, Liszka H, King DE, Egan BM (2004) Prehypertension and mortality in a nationally representative cohort. Am J Cardiol 94(12): 1496-1500.
21. Terry PD, Abramson JL, (2007) Neaton JD; MRFIT Research Group (2007) Blood pressure and risk of death from external causes among men screened for the Multiple Risk Factor Intervention Trial. Am J Epidemiol 165(3): 294-301.
22. Hsia J, Margolis KL, Eaton CB, Wenger NK, Allison M, et al. (2007) Prehypertension and cardiovascular disease risk in the Women's Health Initiative. Circulation 115(7): 855-860.
23. Gu Q, Burt VL, Paulose-Ram R, Yoon S, Gillum RF, (2008) High blood pressure and cardiovascular disease mortality risk among U.S. adults: the third National Health and Nutrition Examination Survey mortality follow-up study. Ann Epidemiol 18(4): 302-309.
24. Lee J, Heng D, Ma S, Chew SK, Hughes K, et al. (2009) Influence of pre-hypertension on all-cause and cardiovascular mortality: the Singapore Cardiovascular Cohort Study. Int J Cardiol 135(3): 331-337.
25. Gu D, Chen J, Wu X, Duan X, Jones DW, et al. (2009) Prehypertension and risk of cardiovascular disease in Chinese adults. J Hypertens 27(4): 721-729.
26. Ikeda A, Iso H, Yamagishi K, Inoue M, Tsugane S, (2009) Blood pressure and the risk of stroke, cardiovascular disease, and all-cause mortality among Japanese: the JPHC Study. Am J Hypertens 22(3): 273-280.
27. Pednekar MS, Gupta R, Gupta PC, (2009) Association of blood pressure and cardiovascular mortality in India: Mumbai cohort study. Am J Hypertens 22(10): 1076-1084.
28. Dorjgochoo T, Shu XO, Zhang X, Li H, Yang G, et al. (2009) Relation of blood pressure components and categories and all-cause, stroke and coronary heart disease mortality in urban Chinese women: a population-based prospective study. J Hypertens 27(3): 468-475.
29. Lorenzo C, Aung K, Stern MP, Haffner SM, (2009) Pulse pressure, prehypertension, and mortality: the San Antonio heart study. Am J Hypertens 22(11): 1219-1226.
30. Hozawa A, Kuriyama S, Kakizaki M, Ohmori-Matsuda K, Ohkubo T, et al. (2009) Attributable risk fraction of prehypertension on cardiovascular disease mortality in the Japanese population: the Ohsaki Study. Am J Hypertens 22(3): 267-272.
31. Kim NH, Cho HJ, Kim YJ, Cho MJ, Choi HY, et al. (2011) Combined effect of high-normal blood pressure and low HDL cholesterol on mortality in an elderly Korean population: the South-West Seoul (SWS) study. Am J Hypertens 24(8): 918-923.
32. Gombojav B, Yi SW, Sull JW, Nam CM, Ohrr H, (2011) Combined effects of cognitive impairment and hypertension on total mortality in elderly people: the Kangwha Cohort study.Gerontology. 57(6): 490-496.
33. Isezuo SA, Sabir AA, Ohwovorilole AE, Fasanmade OA, (2011) Prevalence, associated factors and relationship between prehypertension and hypertension: a study of two ethnic African populations in Northern Nigeria. J Hum Hypertens 25 (4): 224-230.
34. Janghorbani M, Amini M, Gouya MM, Delavari A, Alikhani S, et al. (2008) Nationwide survey of prevalence and risk factors of prehypertension and hypertension in Iranian adults. J Hypertens 26(3): 419-426.
35. Sun Z, Zheng L, Wei Y, Li J, Zhang X, et al. (2007) Prevalence and risk factors of the rural adult people prehypertension status in Liaoning Province of China. Circ J 71(4): 550-553.
36. Gupta AK, McGlone M, Greenway FL, Johnson WD, (2010) Prehypertension in disease-free adults: a marker for an adverse cardiometabolic risk profile. Hypertens Res 33(9): 905-910.
37. Wang Y, Wang QJ, (2004) The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem. Arch Intern Med 164: 2126-2134.
38. Egan BM, Lackland DT, Jones DW, (2010) Prehypertension: an opportunity for a new public health paradigm. Cardiol Clin 28(4): 561-569.
39. Vasan R, Larson MG, Leip EP, Kannel WB, Levy D, (2002) Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 358: 1682-1686.
40. Zhang H, Thijs L, Kuznetsova T, Fagard RH, Xinli L, et al. (2006) Progression to hypertension in the non-hypertensive participants in the Flemish Study on Environment, Genes and Health Outcomes. J Hypertens 24: 1719-1727.
41. Conen D, Ridker PM, Buring JE, Glynn RJ, (2007) Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study. BMJ 335: 432.
42. Murakami Y, Hozawa A, Okamura T, Ueshima H, Evidence for Cardiovascular Prevention From Observational Cohorts in Japan Research Group (EPOCH-JAPAN) (2008) Relation of blood pressure and all-cause mortality in 180,000 Japanese participants: pooled analysis of 13 cohort studies. Hypertension 51(6): 1483-1491.
43. Julius S, Nesbitt SD, Egan BM, Weber MA, Michelson EL, et al. (2006) Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med 354: 1685-1697.
44. Lüders S, Schrader J, Berger J, Unger T, Zidek W, et al. (2008) The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League. J Hypertens 26: 1487-1496.
45. Sipahi I, Swaminathan A, Natesan V, Debanne SM, Simon DI, et al. (2012) Effect of antihypertensive therapy on incident stroke in cohorts with prehypertensive blood pressure levels: a meta-analysis of randomized controlled trials. Stroke 43(2): 432-440.